Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP?

E. Prina, O. T. Ranzani, E. Polverino, C. Cillóniz, M. Ferrer, L. Fernandez, J. Puig de la Bellacasa, R. Menéndez, J. Mensa, A. Torres (Barcelona, Valencia, Spain; São Paulo, Brazil)

Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Session: Epidemiology, scores and outcomes of respiratory infections
Session type: Thematic Poster Session
Number: 2475
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Prina, O. T. Ranzani, E. Polverino, C. Cillóniz, M. Ferrer, L. Fernandez, J. Puig de la Bellacasa, R. Menéndez, J. Mensa, A. Torres (Barcelona, Valencia, Spain; São Paulo, Brazil). Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP?. Eur Respir J 2014; 44: Suppl. 58, 2475

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community-acquired pneumonia due to multidrug and non-multidrug resistant pseudomonas aeruginosa
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Pseudomonas aeruginosa pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Klebsiella respiratory infection community acquired
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013


Molecular mechanisms and virulence of colistin-resistant klebsiella pneumoniae
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016


What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009



Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
Source: Eur Respir J 2010; 35: 598-615
Year: 2010



Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Clinical implications of agr operon activity in staphylococcus aureus strains isolated from respiratory samples
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015


Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA)
Source: Eur Respir J 2007; 30: Suppl. 51, 407s
Year: 2007

Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Year: 2006


Genotyping of extended spectrum-beta-lactamases (ESBLs) detected cephalosporin-resistant escherichia coli and klebsiella species in Japan
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Frequency of multidrug resistant pathogens in healthcare associated pneumonia
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?
Source: Eur Respir J 2010; 35: 473-474
Year: 2010


Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016

Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009



Emerging macrolide-resistant mycoplasma pneumoniae in Thailand
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002



PES (Pseudomonas , Enterobacteriaceae S. Aureus MR) a new clinical acronym to identify MDR pneumonias in the community
Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia
Year: 2014